The association between hormone fluctuations during the menstrual cycle and human immunodeficiency virus type 1 (HIV-1) RNA shedding in cervical and vaginal secretions was examined daily for 17 HIV-1-seropositive women, for the duration of 1 cycle. Serum levels of RNA were evaluated 3 times/week. A marginally significant positive correlation between serum levels of progesterone and serum levels of HIV-1 RNA ( ) was P p .04 observed. Cervical virus levels were significantly correlated with the number of days from the midcycle surge in luteinizing hormone (LH) ( ). The lowest levels of cervical HIV-1 RNA were present at the LH P p .008 surge, and this nadir was followed by an increase in virus levels that reached a maximum before the start of menses. In contrast, there was no significant association between the number of days from the LH surge and the level of HIV-1 RNA in vaginal secretions ( ). These data support the hypothesis that the level of P p .4 HIV-1 RNA in cervical secretions is influenced by the menstrual cycle, and they suggest that the risk of heterosexual transmission of HIV-1 may increase as menses is approached.
Heterosexual contact, which is the most common mode of transmission of HIV-1, involves exposure to virus in mucosal secretions. Efforts to prevent further spread of the HIV-1 pandemic are thus likely to benefit from a detailed understanding of the determinants of virus levels in genital secretions. Cross-sectional studies of women have demonstrated a positive association between the use of hormonal contraceptives and the detection of HIV-1-infected cells in genital samples [1, 2] . These studies imply an association between exogenous female reproductive hormones and the presence of virus in the genital tract, and they also suggest a potential association between cyclic fluctuations in lev-els of endogenous hormones during the menstrual cycle and shedding of HIV-1 in genital secretions.
Several studies have examined mucosal virus levels at different times during the menstrual cycle, to evaluate the influence of endogenous hormones on virus shedding; however, these studies have generated variable results, with evidence both for and against an impact of endogenous hormones on genital levels of virus [3] [4] [5] [6] [7] [8] [9] . These discrepancies may stem from a limited potential to accurately examine fluctuations in virus levels with respect to an individual's cycle, because of infrequent sample collection, inability to establish the timing of the luteinizing hormone (LH) surge, or both [3, 4, 6, 7, 9] . In addition, the use of sampling techniques, such as lavage, that may have allowed mixing of vaginal and cervical secretions has impeded evaluation of virus levels in distinct compartments of the female genital tract [6, 7] . Finally, in most studies conducted to date, the ability to make quantitative correlations between virus levels and hormonal changes has been limited by a low frequency of detection of HIV-1 in genital secretions, either because of the insensitivity of the virus-detection methods used or because of the use of antiretroviral therapy by a significant fraction of the cohort [3] [4] [5] [6] 9] . Of the 4 studies that quantified genital HIV-1 RNA levels on a weekly basis [4, 6, 7, 9] , 2 studies demonstrated increased virus levels in cervical and vaginal secretions during the week of menses, followed by a decrease in virus levels during the follicular and/or periovulatory phases [6, 9] . In these studies, the precise timing of this decrease in virus levels was not well defined, perhaps because of a low frequency of detection of HIV-1 RNA (34%-55%) together with limited sampling [6, 9] . To generate a comprehensive profile of day-to-day shedding of virus at discrete sites in the genital tract during the menstrual cycle, we used a highly sensitive HIV-1 RNA assay [10] to quantify virus levels in vaginal and cervical swab specimens that were obtained daily, for the duration of 1 menstrual cycle, from 17 antiretroviral-naive women. The LH surge in these women was determined by daily monitoring, so that data for each woman could be examined in relation to the precise timing of her ovulation [5] . Levels of HIV-1 RNA in serum samples obtained 3 times/week were also assessed, to allow for comparison of systemic levels of virus with genital levels of virus over time.
METHODS
Study design and data collection. Details regarding the cohort evaluated in the present study have been described elsewhere [5] . The cohort was restricted to women who were HIV-1 seropositive, who reported having regular menstrual cycles, who had not used hormonal contraception or an intrauterine device during the 6 months before the study, and who had not undergone a hysterectomy. All individuals in the cohort were antiretroviral naive. Informed consent was obtained from all study participants. This research was approved by human subjects review committees at the Fred Hutchinson Cancer Research Center (Seattle, WA), the University of Washington (Seattle), and the University of Nairobi (Nairobi, Kenya).
Participants were requested to begin a series of daily clinic visits on the first or second day of menses and to continue these visits until the start of their next menstrual cycle. Participants attended 451 (98%) of 458 of expected visits overall. At every visit, endocervical and vaginal secretions were obtained using a Dacron swab, which was promptly immersed in 1 mL of freezing media (70% RPMI 1640, 20% fetal calf serum, and 10% DMSO), kept on ice, and stored at Ϫ70ЊC within 4 h of sample collection. One investigator (S.B.M.) obtained all genital specimens. Urine samples were obtained daily to ascertain the LH surge. Blood samples were obtained 3 times/week, for quantitation of serum levels of estradiol, progesterone, and HIV-1 RNA. Participants underwent screening for sexually transmitted diseases, bacterial vaginosis, and vaginal candidiasis before the start of their daily clinic visits and at weekly intervals thereafter. Samples were also obtained, on a weekly basis, for determination of vaginal and cervical polymorphonuclear leukocyte counts and for detection of Lactobacillus species. At each clinic visit, women were asked to report any douching or sexual activity that occurred during the previous 24 h.
Laboratory analysis.
Swab and serum samples were shipped, on dry ice, to Seattle and were stored in liquid nitrogen or at Ϫ70ЊC, respectively, for subsequent HIV-1 RNA analysis. The Gen-Probe HIV-1 load assay (Gen-Probe) was used to quantitate HIV-1 RNA levels in genital swab specimens and in serum samples [10, 11] . This assay has been validated for quantitation of HIV-1 subtypes A, C, and D [10] , which were the subtypes found in the 17 women who participated in the present study [5] . Swab specimens were not previously manipulated. They were thawed in freezing media at room temperature and were vortexed, and 200 mL of sample material was immediately added to assay lysis buffer. Serum samples were similarly processed, with the exception that 10-400 mL of the sample material was added to lysis buffer, depending on the amount that was available for testing. For genital samples, the limit of quantitation for the assay is у3.5 copies/reaction, or 18 HIV-1 RNA copies/swab, because one-fifth of the sample material was tested; for serum samples, the limit of quantitation for the assay is 9-350 copies/mL, depending on the amount of sample material tested [11] .
Statistical methods. Censored observations for serum, cervical, and vaginal levels of virus were converted to the midpoint between zero and the lower limit of detection. The standard deviations (SDs) for the log 10 values of the serum, cervical, and vaginal virus loads of each study participant were compared, between sample types, using the Friedman rank sum test (version 10.0; SPSS). For this comparison of SDs, pairwise comparisons between groups were performed, and, to adjust for multiple comparisons, only P values !.02 were considered to be statistically significant. Generalized estimating equations (STATA, version 7.0; StataCorp), with a Gaussian link for data for cervical and serum samples and with either a Gaussian or a binomial link for data for vaginal samples, were used to identify correlates of HIV-1 RNA shedding. For all models, an autoregressive correlation structure with a robust variance estimator was used. These models do not accommodate missing observations; therefore, any gaps in the data were interpolated or imputed. Conditions that were ascertained weekly were imputed as positive 4 days before and 4 days after a diagnosis was made. Linear interpolation was used to estimate the missing observations for serum, cervical, and vaginal virus loads, serum levels of estradiol and progesterone, and measurements of vaginal pH. Regression of detection of vaginal HIV-1 RNA on interpolated cervical In both panels, the X-axis is centered on the day on which the LH surge was observed (day 0). Data for participant 17 were excluded from these results, because the LH surge of this participant was not detected [5] . Shaded areas of the figure denote days on which there were р14 observations, because of variations in the length of the women's cycles. virus levels was performed to impute values for the detection of vaginal HIV-1 RNA, when those values were missing. Missing data for the detection of HIV-1-infected cells in vaginal and cervical samples were imputed using a similar regression on interpolated serum levels of virus. Missing observations for all other variables were imputed by a regression on the number of days from the LH surge. With the exception of measurements of serum HIV-1 RNA and hormone, !2% of the observations were missing; thus, the effect of any inappropriately imputed values should be minimal. Interpolated serum levels of virus were used for analysis of the serum virus load and the number of days from the LH surge, but only observed serum HIV-1 RNA values were used for analyses of associations with levels of either serum estradiol or progesterone. Variables were included in the multivariate model if the univariate model showed a trend ( ) toward a significant association with shedding of HIV-P р .1 1 RNA. Because of colinearity, the serum level of estradiol and the number of days from the LH surge were evaluated in separate multivariate models for cervical virus shedding.
RESULTS

Levels of HIV-1 RNA in serum, cervical, and vaginal samples.
For each woman who participated in the study, detection of HIV-1 RNA in serum samples was consistent (median percent positivity, 100%; range, 85%-100%), and detection of HIV-1 RNA in cervical samples was generally consistent (median percent positivity, 97%; range, 29%-100%); however, detection in vaginal specimens was less frequent (median percent positivity, 74%; range, 25%-100%) (table 1). Ninety-eight percent, 89%, and 70% of serum, cervical, and vaginal samples, respectively, had RNA levels above the level of detection of the HIV-1 RNA assay. Among women, the median of virus levels was 26,690 copies/mL (range, 17-305,400 copies/mL) for serum samples, 3578 copies/swab (range, !18-141,445 copies/swab) for cervical secretions, and 386 copies/swab (range, !18-49,585 copies/ swab) for vaginal secretions. Within women, we found increased variability in virus levels at mucosal sites-in particular, in vaginal secretions. Consistent with this observed variability within subjects, a between-group comparison of the SDs of the log 10 virus load values of each individual, for the 3 sample types, revealed significant differences between each site, with the highest SDs corresponding to the vaginal compartment (median, 1.0 log 10 copies/swab; range, 0.2-1.6 log 10 copies/swab), compared with the systemic compartment (median, 0.3 log 10 copies/ mL; range, 0.1-1.7 log 10 copies/mL) and the cervical compartment (median, 0.7 log 10 copies/swab; range, 0.2-0.9 log 10 copies/ swab) ( , by the Friedman rank sum test). P ! .001 Association between hormone levels and HIV-1 RNA levels in serum and in vaginal and cervical secretions. To characterize the hormone levels of these women, serum levels of estradiol and progesterone were measured 3 times/week; 16 of 17 women had normal hormonal profiles that were indicative of an ovulatory cycle (table 2) [5] . We assessed whether hormonal fluctuations during the menstrual cycle were associated with the level of systemic or genital virus or with the detection of systemic or genital virus. For the systemic compartment, neither the number of days from the LH surge ( ; figure P p .3 1A) nor the serum level of estradiol ( ) was significantly P p .5 associated with the serum virus load in univariate analyses; however, there was a marginally significant association between the progesterone level and the serum virus load ( ; table P p .04 3). Here, there was an increase of 0.09 log 10 HIV-1 RNA copies/ mL for each 5-ng/mL increase in the serum level of progesterone. However, this association is not reflected by the average daily levels of serum progesterone and serum HIV-1 RNA, as plotted by the day of the menstrual cycle (figure 1B).
For the vaginal compartment, we evaluated the association between the potential correlates of virus shedding and the level of virus in vaginal secretions. In univariate analyses, the serum virus load ( ), the presence of menses at examination P ! .001 ( ), and the detection of HIV-1-infected cells in vaginal P p .009 secretions ( ) were associated with increased levels of P ! .001 HIV-1 RNA in vaginal specimens ( In both panels of the figure, the X-axis is centered on the day on which the LH surge was observed (day 0). For day Ϫ10 through day Ϫ6, visible blood was present either on the cervical or vaginal swab or in cervical or vaginal secretions, for up to 11 participants on any given day. On day Ϫ5 through day 12, visible blood was noted for no more than 2 participants on any given day, with the exception of day 10 (a day on which visible blood was noted for 3 participants). Data for participant 17 were excluded from these results, because the LH surge of this participant was not detected [5] . Only days for which there were р14 observations (see figure 1) were included.
did not observe a significant association between the number of days from the LH surge and the virus levels in vaginal samples (table 4; figure 2A ).
The relatively low frequency of detection of HIV-1 RNA in vaginal samples (70%) may have rendered the use of a quantitative analysis less appropriate for these data. Therefore, we also evaluated potential correlates of vaginal virus shedding, as judged by the presence or absence of virus, in a qualitative analysis. In a multivariate model that adjusted for the number of days from the LH surge, presence of bacterial vaginosis, and detection of HIV-1-infected cells in vaginal secretions, serum levels of virus ( ) and the presence of menses ( P p .02 P p ) were both significantly associated with increased odds of .05 detection of virus in vaginal samples (data not shown). Douching with soap or detergent was significantly associated with decreased odds of detection of virus in vaginal samples (P p ). There was no indication of an association between hor-.002 mone levels and detection of virus in vaginal samples, by multivariate analyses, and there was no evident pattern in the proportion of RNA-positive vaginal swab specimens, by the day of the menstrual cycle (figure 2B).
For cervical swab specimens, the serum virus load strongly predicted cervical levels of virus in univariate analyses (P !  ; table 5 ). There was a significant association between the .001 HIV-1 RNA level in cervical secretions and the number of days from the LH peak ( ), and cervical levels of HIV-1 RNA P p .02 were inversely correlated with serum levels of estradiol (P p ). Unprotected sex ( ) and douching with soap or .03 P p .02 detergent during the 24 h before a clinic visit ( ) were P p .05 also inversely associated with cervical virus levels. In multivariate analyses, the associations between cervical virus levels and both unprotected sex and douching were no longer statistically significant. In this model, which adjusted for the serum virus load, unprotected sex, douching, and the presence of menses at examination, there was an increase of 0.04 log 10 copies/swab in the HIV-1 RNA level detected in cervical secretions, as the number of days from the LH surge increased (
). There also P p .008 remained a positive significant association between serum and cervical levels of HIV-1 RNA ( ).
The striking association between the number of days from the LH surge and cervical HIV-1 RNA levels led us to examine the multivariate model for cervical virus shedding in greater detail. Multivariate analysis predicts that, after menses, cervical HIV-1 RNA levels gradually decrease until the LH surge and then gradually increase before the start of the next menses. To assess whether the observed cervical HIV-1 RNA values agreed with this model, each woman's cervical virus load value on day 0 was subtracted from all her other cervical virus load values. These centered values for the 16 ovulatory women are presented in figure 3 [5] and are summarized as means ‫ע‬ SDs for all values available on a given day. Figure 3 illustrates the association predicted by the multivariate model, and it depicts a cyclical pattern of virus shedding, in which virus levels are minimal at the LH surge and subsequently increase during the luteal phase.
DISCUSSION
This is the first study to describe the daily changes in the HIV-1 RNA levels in cervical and vaginal compartments in association with the menstrual cycle. We show that cervical virus Activity occurring during the 24 h before a clinic visit Douching with soap or detergent Ϫ0.5 (Ϫ0.9 to 0.01) .05
Having unprotected sex Ϫ0.3 (Ϫ0.5 to Ϫ0.04)
.02
Presence of menses at examination 0. levels were lowest at the time of the LH surge and then increased before the onset of the next menses. We did not find a significant association between the menstrual cycle and the level of HIV-1 RNA in vaginal secretions. The present analysis suggests that there is an association between fluctuations in endogenous hormone levels and the HIV-1 RNA level in cervical secretions. Systemic levels of virus were monitored 3 times/week, and we observed significant associations between the serum virus load and the level of virus in both the vaginal and cervical compartments. We also evaluated the association between hormonal changes and systemic levels of HIV-1 RNA. There was a positive correlation between progesterone levels and serum HIV-1 RNA levels ( ). Of the 4 other studies that ex-P p .04 amined the association between the menstrual cycle and systemic levels of virus [6, 7, 9, 13] , 1 study found a statistically significant decrease in serum virus levels between the early follicular phase and the midluteal phase [13] . This finding contrasts with the present analysis, which suggests a potential increase in virus levels during the luteal phase. However, the association that we observed between serum levels of progesterone and serum levels of HIV-1 RNA was lost ( ) on P p .1 exclusion of 1 outlying progesterone observation, which was 4.3 SDs above the mean. Furthermore, a limitation of the use of generalized estimating equations in the present analysis is that, for small sample sizes, the type 1 error rate may be inflated [14] . This fact, together with the influence of the outlying progesterone observation, indicates that it may be premature to speculate on the biological relevance of this result.
We did not find a significant association between hormone levels and levels of HIV-1 RNA in vaginal secretions. Overall, virus levels were lower and virus was detected less frequently in vaginal secretions than in cervical secretions. Although the power of the present analysis was strengthened by the intensive sampling frame of the study, we cannot exclude the possibilities that the increased variability in virus levels noted in vaginal specimens or the lack of detection of HIV-1 RNA in 30% of vaginal samples impeded our ability to detect a significant association. We observed greater variation in genital samples than , for all observations available on a given day. The X-axis is centered on the day on which the LH surge was observed (day 0). Detection of blood on swab specimens or in genital secretions is as described in the figure 2 legend. Data for participant 17 were excluded from these results because the LH surge of the participant was not detected [5] . Only days for which there were at least 14 observations (see figure 1) were included.
in serum samples, and the highest degree of variability was observed in vaginal virus levels. Increased variability may have been caused, in part, by the inherent variability in sampling associated with obtaining a swab specimen versus a set amount of blood. Lower levels of virus in genital secretions, especially in vaginal samples, could also contribute to increased variability, because the HIV-1 RNA assay shows more variation at lower levels of HIV-1 RNA [10] .
In quantitative multivariate analysis of vaginal virus shedding, there were significant positive associations of both the presence of menses at examination and the detection of HIV-1-infected cells in vaginal secretions with the level of HIV-1 RNA in vaginal samples. A previous study of vaginal Sno-Strip specimens found an increased level of virus in vaginal secretions during the week of menses, compared with the levels noted in the follicular and periovulatory phases, although statistical analysis did not adjust for repeat testing [9] . In another report [7] , virus levels in vaginal lavage specimens were not significantly different from week to week, although levels were not evaluated during the week of menses, and this interpretation is also based on an analysis that did not adjust for repeat testing. In qualitative multivariate analysis, we observed a strong association between douching that occurred during the 24 h before a clinic visit and a decreased odds of detection of HIV-1 RNA in vaginal samples. It is possible that the presence of residual soap or detergent in genital secretions may have led to viral lysis or RNA degradation or that they may have compromised the performance of the HIV-1 RNA assay. Regardless of the basis for the effect of douching on detection of vaginal HIV-1 RNA, there still was no observed association between hormonal changes and detection of HIV-1 RNA in vaginal secretions when douching was included in the multivariate model.
We observed a cyclic pattern of HIV-1 RNA levels in cervical secretions during the menstrual cycle. These results contrast with those of a previous examination of HIV-1 proviral DNA, which used duplicate specimens obtained from the same cohort evaluated in the present study and which did not demonstrate an association between the menstrual cycle and detection of HIV-1-infected cells [5] . It is not clear whether this discrepancy is the result of the qualitative nature of the earlier analysis or of a specific effect of the menstrual cycle on levels of HIV-1 RNA versus levels of HIV-1-infected cells in cervical secretions. A quantitative analysis of levels of HIV-1 provirus in the female genital tract throughout the menstrual cycle is needed to address this further.
The findings of the present study support and extend the results of 2 previous studies in which a decrease in genital HIV-1 RNA was estimated to occur during the follicular and/or periovulatory phase of the cycle. In these studies, the decrease in virus levels could not be definitively characterized, because sampling occurred only on a weekly basis and because of a low frequency of HIV-1 RNA detection [6, 9] . Nevertheless, the nadir of cervical HIV-1 RNA levels observed in the present study occurred within the general time frames in which cervical virus levels were lowest in samples obtained on a weekly basis. Of interest, each study used distinct techniques for obtaining genital samples, including methods that specifically obtained fluids as well as those that obtained mucosal cells, providing further evidence that hormonal changes affect virus shedding. We did not observe an association between cervical virus shedding and the presence of menses (table 5) , and this factor alone could not account for the daily incremental increases in virus levels that occur very soon after ovulation, well in advance of visible blood. Moreover, exclusion of data for days on which the presence of menses was noted at examination from the statistical analysis did not substantially alter the results of the multivariate cervical HIV-1 RNA analysis (data not shown). Of note, although the present analysis suggests that the overall average increase in cervical HIV-1 RNA levels, between the LH surge and menses, is 0.04 log 10 copies/swab per day, restriction of the multivariate analysis to shorter time segments suggests that the largest increases occur within 2 days of the LH surge. Restriction of the analysis to day Ϫ7 through day +7 suggests that the increase in cervical HIV-1 RNA levels is 0.07 log 10 copies/swab specimen per day ( ), and restriction of P p .002 analysis to day Ϫ2 through day +2 suggests that the increase in cervical virus levels is 0.2 log 10 copies/swab per day (P p ; data not shown). .05
In the present study, virus levels in cervical specimens were lowest at midcycle, relative to other phases of the menstrual cycle; this finding suggests an association between female reproductive hormones and genital virus levels. There are many physiological changes in the cervical mucosa during the menstrual cycle, including fluctuations in the level of secretions [15] , that could change the concentration of virus or increase the friability of the epithelium. However, we did not find an association between the amount of cervical mucus at examination and cervical virus levels. In addition, consistent with the findings of other studies, the presence of visible blood in cervical specimens or in cervical secretions, at sample collection, was not associated with cervical virus levels (data not shown) [6, 16] . The fluctuations in virus levels that we observed during the menstrual cycles of the women studied suggest that reproductive hormones can affect the level of virus production or the number of productively infected cells within the genital mucosa. These changes may be the result of direct effects of hormones on virus replication and/or may occur indirectly, through the effects of hormones on either the availability or the susceptibility of HIV-1 target cells to viral infection. This model could also explain the results of 2 studies that have shown a positive association between the use of hormonal contraceptives and the detection of HIV-1-infected cells in genital secretions [1, 2] , as well as those of a prospective study that found increased detection of HIV-1-infected cells after initiation of hormonal contraceptive use [17] . Hormonal influences in the microenvironment of the genital tract that are conducive to virus replication may also explain the increased viral diversity seen early during infection in women who use hormonal contraceptives [18] . Mechanisms for a hormonal effect on production of virus have been suggested by in vitro studies demonstrating regulation of the HIV-1 long-terminal repeat by steroid hormone receptors [19] [20] [21] and alterations in expression of chemokine receptors after progesterone treatment [22, 23] . In addition, surface expression of the CCR5 chemokine receptor was increased on endocervical CD4 + T lymphocytes in women who were using oral contraceptives [24] . Reproductive hormones may also exert indirect effects on virus replication, as suggested by small clinical studies that report differences in immune function in the genital tract during the menstrual cycle [25] [26] [27] [28] [29] . Together, such studies encourage further examination of the potential role of hormonal fluctuations in regulating the level of virus in the genital tract. The present analysis underscores the importance of the menstrual cycle in studies that attempt to characterize the determinants of virus shedding in the female genital tract. Of importance, the present study also implies there may be more risk of transmission of HIV-1 at certain times during the menstrual cycle.
